Immediate Impact
1 by Nobel laureates 14 from Science/Nature 64 standout
Citing Papers
Cancer neuroscience: State of the field, emerging directions
2023 Standout
SynergyFinder 3.0: an interactive analysis and consensus interpretation of multi-drug synergies across multiple samples
2022 Standout
Works of Lucy Matthews being referenced
Do drugs offering only PFS maintain quality of life sufficiently from a patient’s perspective? Results from AVALPROFS (Assessing the ‘VALue’ to patients of PROgression Free Survival) study
2018
Therapeutic aims of drugs offering only progression-free survival are misunderstood by patients, and oncologists may be overly optimistic about likely benefits
2016
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Lucy Matthews | 77 | 30 | 134 | 174 | 21 | 395 | |
| Carol Chu | 107 | 70 | 272 | 148 | 17 | 445 | |
| Marta De Santis | 53 | 8 | 63 | 156 | 20 | 410 | |
| Ashley Crook | 96 | 51 | 82 | 57 | 26 | 347 | |
| Victor Evangelista de Faria Ferraz | 45 | 47 | 185 | 96 | 33 | 361 | |
| Clesson Turner | 54 | 60 | 223 | 213 | 35 | 453 | |
| Monica A. Giovanni | 20 | 17 | 145 | 190 | 12 | 447 | |
| Arjun Bhattacharya | 35 | 43 | 134 | 207 | 25 | 457 | |
| Kathleen Klein | 48 | 49 | 56 | 123 | 31 | 340 | |
| Lilian Pek Lian Lau | 15 | 26 | 209 | 129 | 11 | 420 | |
| Jennyfer M. García-Cárdenas | 72 | 103 | 70 | 187 | 34 | 418 |
All Works
Login with ORCID to disown or claim papers
Loading papers...